Table 3.
Presence of significant lesions according to age at entry into surveillance study
| Age at entry into surveillance study | ||||||
|---|---|---|---|---|---|---|
| <55 (n=61) | 55–64 (n=31) | >=65 (n=17) | ||||
| Significant prevalent lesion | # | % | # | % | # | % |
| Yes | 2 | 3 | 1 | 3 | 6 | 35 |
| No | 59 | 97 | 30 | 97 | 11 | 65 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.